Havana Cuba Business Travel Culture and Politics

Havana Cuba News

Cuba Culture News

Posted November 05, 2007 by publisher in Cuban Healthcare

Email this article | Print this article | Search Havana Journal        

Prensa Latina

With the attendance of experts from over 20 nations, the International Congress “Biotecnologia Habana 2007” starts in this capital Monday, to analyze current bio-production trends.

Eduardo Martinez, director of Technological Development at the Genetic Engineering and Biotechnology Center, said that the meeting will center for the first time in updating the conversion of scientific results in industrial productions.

Cuba must hold this kind of gathering for having reached “larger capacities and infrastructure for the production of biological products with first-world standards, Martinez noted.

The congress’ scientific sessions, to be run until November 9, are divided in seven symposiums.

Another important aspect, he stated, will be experiences in transgenic tobacco plants as bi-reactors to produce bio-molecules to produce human vaccines, of which Cuba is a world pioneer.

Since the mid 80s of last century, Cuba began an accelerated development of biotechnology, generating unique products like the meningococcal type B vaccine.

Would you like to add more information?

Only members can add more information. Please register or log in

  • Advertise at Havana Journal Inc
We recommend this AirBnB Food and Drink Experience... Cuban flavors: Food, Rum and Cigars
Images of Cuba
Plaza de Armas en Habana Vieja Cuba
Follow Havana Journal
SUBSCRIBE to our Cuba Watch newsletter
LIKE us on Facebook

FOLLOW us on Twitter

CONNECT with us on Linked In

Section Archive
Havana Journal, Inc. BBB Business Review

Member of the Association for the Study of the Cuban Economy